CSPC Pharmaceutical Group Ltd 01093.HK

CSPC Pharmaceutical Group Limited manufactures and sells a wide variety of health-related products. The China-based company sells antibiotics, generic drugs and vitamin C. CSPC Pharmaceutical sells over 1,000 different products through its numerous subsidiaries including China Pharma, NBP, Weisheng, Zhongnuo, and Zhongrun. China Pharma, one of the company’s biggest subsidiaries, is based in Hong Kong and is listed on the Hang Seng China-Affiliated Corporations Index.

Listed as 01093.HK, CSPC Pharmaceutical has been listed on the Stock Exchange of Hong Kong since 1994 and is also part of the Hang Seng Index. 01093.HK stock went public in 2017, with CSPC Pharmaceutical looking to raise HK$2 billion at around HK$12.50 per share. 157 million shares were made available during the IPO.

While primarily focusing on Western medicine, CSPC Pharmaceutical also offers more traditional Chinese medicinal options. When it comes to its Western offerings, CSPC Pharmaceuticals has completed the research and development of cardiovascular, diabetes, neurology and oncology medicines. Aside from pharmaceuticals, the company also provides sewage processing services.

Find out if CSPC Pharmaceutical stock is right for you. Learn more on the eToro platform.